NKGen Biotech, Inc.
NKGN
$0.1381
$0.00261.92%
OTC PK
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -8.26% | -0.32% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.97% | -2.15% | |||
| Operating Income | 8.97% | 2.15% | |||
| Income Before Tax | 141.01% | -198.92% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 141.01% | -198.92% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 141.01% | -198.92% | |||
| EBIT | 8.97% | 2.15% | |||
| EBITDA | 9.38% | 2.22% | |||
| EPS Basic | 134.02% | -171.27% | |||
| Normalized Basic EPS | 67.89% | -390.19% | |||
| EPS Diluted | 122.92% | -171.27% | |||
| Normalized Diluted EPS | 77.37% | -390.19% | |||
| Average Basic Shares Outstanding | 20.54% | 10.18% | |||
| Average Diluted Shares Outstanding | 71.01% | 10.18% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||